SCHEMBL10151491

SCHEMBL10151491

CC(C)CC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12958542 1.00 LMNA (0.33) LMNA
SCHEMBL12958543 1.00 LMNA (0.33) LMNA
SCHEMBL10151490 1.00 LMNA (0.33) LMNA
SCHEMBL12958557 1.00 LMNA (0.33) LMNA
SCHEMBL12868816 1.00 LMNA (0.33) LMNA
SCHEMBL12958561 1.00 LMNA (0.33) LMNA
SCHEMBL12958546 1.00 LMNA (0.33) LMNA
SCHEMBL10151493 1.00 LMNA (0.33) LMNA
SCHEMBL10151492 1.00 LMNA (0.33) LMNA
SCHEMBL7925091 1.00 LMNA (0.33) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210369866-A1 BIODEGRADABLE LIPIDS FOR DELIVERY OF NUCLEIC ACIDS TRANSLATE BIO, INC. 2021-12-02 US disclosed
US-20210101875-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-04-08 US disclosed
US-10959953-B2 Lipid formulations for delivery of messenger RNA TRANSLATE BIO, INC. (US) 2021-03-30 US disclosed
US-10933139-B2 Conjugated lipomers and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-03-02 US disclosed
US-10912844-B2 Biodegradable lipids for delivery of nucleic acids TRANSLATE BIO, INC. (US) 2021-02-09 US disclosed
US-10844028-B2 Aminoalcohol lipidoids and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2020-11-24 US disclosed
US-20200222558-A1 BIODEGRADABLE LIPIDS FOR DELIVERY OF NUCLEIC ACIDS RANA THERAPEUTICS, INC. 2020-07-16 US disclosed
US-10682374-B2 Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof MASSACHUSETTS INTSTITUTE OF TECHNOLOGY (US) 2020-06-16 US disclosed
US-20190177289-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2019-06-13 US disclosed
US-20190167795-A1 CONJUGATED LIPOMERS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2019-06-06 US disclosed
US-20150140070-A1 LIPID FORMULATIONS FOR DELIVERY OF MESSENGER RNA TRANSLATE BIO, INC. 2015-05-21 US disclosed
US-8969353-B2 Aminoalcohol lipidoids and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-03-03 US disclosed
US-20140322309-A1 ALPHA-AMINOAMIDINE POLYMERS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLO (US) 2014-10-30 US disclosed
US-20130302401-A1 POLY(BETA-AMINO ALCOHOLS), THEIR PREPARATION, AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2013-11-14 US disclosed
US-20130158021-A1 AMINO ACID-, PEPTIDE-AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2013-06-20 US disclosed
US-8450298-B2 Aminoalcohol lipidoids and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2013-05-28 US disclosed
US-20120251560-A1 CONJUGATED LIPOMERS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2012-10-04 US disclosed
WO-2012027675-A2 POLY(BETA-AMINO ALCOHOLS), THEIR PREPARATION, AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2012-03-01 WO disclosed
US-20110293703-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2011-12-01 US disclosed
US-20100331234-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2010-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (16 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10959953-B2 Lipid formulations for delivery of messenger RNA RNMT, NSUN3, IGF2BP3 LMNA 436/4885
US-20210369866-A1 BIODEGRADABLE LIPIDS FOR DELIVERY OF NUCLEIC ACIDS LIPA, SLC67A1, SREBF1 LMNA 411/4885
US-20140322309-A1 ALPHA-AMINOAMIDINE POLYMERS AND USES THEREOF AAAS, AADAT, INMT LMNA 136/4885
US-20110293703-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF PHOSPHO1, PNMT, AASDHPPT LMNA 314/4885
US-20190167795-A1 CONJUGATED LIPOMERS AND USES THEREOF EZH2, LIPC, PUF60 LMNA 1562/4885
US-10912844-B2 Biodegradable lipids for delivery of nucleic acids LIPA, SLC67A1, SREBF1 LMNA 411/4885
US-20190177289-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF PHOSPHO1, PNMT, AASDHPPT LMNA 314/4885
US-20210101875-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF PHOSPHO1, PNMT, AASDHPPT LMNA 314/4885
US-20120251560-A1 CONJUGATED LIPOMERS AND USES THEREOF EZH2, LIPC, PUF60 LMNA 1562/4885
US-20150140070-A1 LIPID FORMULATIONS FOR DELIVERY OF MESSENGER RNA RNMT, NSUN3, IGF2BP3 LMNA 436/4885
US-20200222558-A1 BIODEGRADABLE LIPIDS FOR DELIVERY OF NUCLEIC ACIDS LIPA, SLC67A1, SREBF1 LMNA 411/4885
US-10933139-B2 Conjugated lipomers and uses thereof EZH2, LIPC, PUF60 LMNA 1562/4885
US-20100331234-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF PHOSPHO1, PNMT, AASDHPPT LMNA 314/4885
US-10844028-B2 Aminoalcohol lipidoids and uses thereof PHOSPHO1, PNMT, AASDHPPT LMNA 314/4885
US-20130158021-A1 AMINO ACID-, PEPTIDE-AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF APLNR, NPPA, ARGLU1 LMNA 1632/4885
US-10682374-B2 Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof APLNR, NPPA, ARGLU1 LMNA 1632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.